Trials / Unknown
UnknownNCT05733299
Aflo™ Device Trial
Automating Patient Inhaler Technique When Using Pressurised Metered Dose Inhalers: Testing the Functionality and Impact of the Aflo™ Digital Respiratory Management Platform in a Randomised Controlled Trial.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- Sponsor
- University of Ulster · Academic / Other
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Accepted
Summary
This randomised, prospective, controlled parallel study aims to evaluate the role and potential of the aflo™ digital platform for improving asthma control, inhalation technique and adherence in patients who use metred dose inhalers (MDI). The study will recruit 104 patients with uncontrolled asthma in the North-West of Northern Ireland. Fifty two patients will remain on standard care over 24-weeks and 52 will combine standard care with the aflo™ platform. The data collected over a 24-week period will be used to determine 1. whether the aflo™platform improves inhalation technique and user adherence to prescribed medication and 2. Lead to better asthma control and reduced symptoms as measured by the Asthma Control Test (ACT). During the study clinicians will be able to remotely monitor and review user analytics via a clinical dashboard. ACT measurements will be recorded at start and end of study. The study aims to test the functionality and impact of automated inhaler technique with real-time feedback, adherence prompts and air quality data sharing for patients who use metered dose inhalers (MDI) using the newly developed aflo™ digital respiratory management platform.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | aflo™ digital respiratory management platform | medical device, user app, clinician portal, data analytics hub |
| OTHER | Standard care | Health service standard care will be continued |
Timeline
- Start date
- 2023-02-06
- Primary completion
- 2024-02-05
- Completion
- 2024-02-05
- First posted
- 2023-02-17
- Last updated
- 2023-02-17
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05733299. Inclusion in this directory is not an endorsement.